Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00958932 · ClinicalTrials.gov registry record · NA

Telecommunication Enhanced Asthma Management

A NA study of Asthma, sponsored by National Jewish Health.

Completed
Registry status
NA
Development phase
1,187
Enrollment target
1
Study location

NCT00958932: Completed NA study of Asthma, sponsored by National Jewish Health.

NCT00958932 is a NA study of Asthma that has completed, run by National Jewish Health. The registered enrollment target is 1,187 participants, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00958932, a NA study of Asthma, has completed, sponsored by National Jewish Health.

COMPLETED
Registry status
NA
Development phase
1,187 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this project is to conduct a randomized practical clinical trial within a large health maintenance organization to test a telephone intervention designed to improve adherence to daily asthma medications and thereby improve asthma outcomes. The investigators hypothesize that adherence with inhaled corticosteroid medications in the TEAM intervention group will be greater than in the usual care group.

Primary Outcome

The primary outcome of this study, adherence, was expressed as a mean proportion of days covered (PDC) over 24 months. The PDC was calculated as the total number of ICS days supplied divided by the period for which the medication was prescribed. Calculation of the PDC was adjusted to account for the supply that would extend beyond the end of the study period. Comparisons were adjusted for baseline PDC, which was calculated as the ratio of number of days a patient had possession of medication div

Conditions Studied

Interventions

  • BEHAVIORAL Speech recognition

Study Locations (1)

Colorado

  • National Jewish Health - Denver

Trial Details

FieldValue
Enrollment Target 1,187 participants
Start Date 2009-09
Est. Completion 2013-05
Phase NA
National Jewish Health

83 total trials

What the finished NCT00958932 record still lists

NCT00958932 is an interventional study that assigns participants to a tested intervention. Its 1,187 participants enrollment target places it among the larger protocols in the corpus, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (24% lower).

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Speech recognition is the first listed.

NCT00958932 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT00958932 about?

NCT00958932 is a clinical study titled "Telecommunication Enhanced Asthma Management". The primary aim of this project is to conduct a randomized practical clinical trial within a large health maintenance organization to test a telephone intervention designed to improve adherence to daily asthma medications and thereby improve asthma outcomes. The investigators hypothesize that adhere...

What is the current status of trial NCT00958932?

This trial is currently completed. It is a NA study. The enrollment target is 1,187 participants. The study started on 2009-09. Estimated completion is 2013-05.

What conditions does trial NCT00958932 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00958932?

The interventions under investigation include: Speech recognition (BEHAVIORAL).

Who is sponsoring clinical trial NCT00958932?

This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00958932 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00958932's enrollment target sits among peer trials

1,187 31st of 374 higher than 344 of 374 other Asthma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05580419 · 1,188 participants · NA

    Impact of 4PCP on Practitioner and Patient Outcomes

  • NCT06290869 · 1,188 participants · Phase 3

    Tobacco Education and Lung Health Study (TEAL)

  • NCT04293562 · 1,186 participants · Phase 3

    A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

  • NCT07286058 · 1,182 participants · Phase 3

    Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00958932, the US trial registry maintained by the National Library of Medicine. NCT00958932 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.